drug

Is lecanemab the drug against Alzheimer's disease that will finally make a difference?

Is lecanemab the drug against Alzheimer’s disease that will finally make a difference?

Leave a Comment / Health / By

In a large study, the experimental drug lecanemab was able to slow Alzheimer’s disease, but not stop it. Some researchers believe that the drug will become the first to help many patients; others have questions. Cemile Bingol/Getty Images hide caption toggle caption Cemile Bingol/Getty Images In a large study, the experimental drug lecanemab was able …

Is lecanemab the drug against Alzheimer’s disease that will finally make a difference? Read More »

Ada County Joins Prescription Drug Rebate Program

Ada County Joins Prescription Drug Rebate Program

Leave a Comment / Medicine / By

An all-new county program includes access to low-cost telemedicine services and increased discounts on prescription drugs. BOISE, Idaho – If you live in Ada County, Idaho, read carefully. There’s a brand new county program that includes access to low-cost telemedicine services and increased discounts on prescription drugs. Ada County recently switched to the Live Healthy …

Ada County Joins Prescription Drug Rebate Program Read More »

Experimental decoy drug tricks coronavirus, then destroys it

Experimental decoy drug tricks coronavirus, then destroys it

Leave a Comment / Medicine / By

The coronavirus has been a sneaky enemy, with new variants and sub-variants rapidly evolving to evade vaccines and treatments. Researchers at Boston’s Dana-Farber Cancer Institute are working on an experimental drug that takes one of the virus’s most dangerous traits – its talent for mutation – and turns it against itself. When the coronavirus binds …

Experimental decoy drug tricks coronavirus, then destroys it Read More »

State seeks federal waiver to cut drug costs

State seeks federal waiver to cut drug costs

Leave a Comment / Health care / By

Country the United States of AmericaUS Virgin IslandsU.S. Minor Outlying IslandsCanadaMexico, United Mexican StatesBahamas, Commonwealth ofCuba, Republic ofDominican RepublicHaiti, Republic ofJamaicaAfghanistanAlbania, People’s Socialist Republic ofAlgeria, People’s Democratic Republic ofAmerican SamoaAndorra, Principality ofAngola, Republic ofAnguillaAntarctica (the territory south of 60 degrees S)Antigua and BarbudaArgentina, Argentine RepublicArmeniaArubaAustralia, Commonwealth ofAustria, Republic ofAzerbaijan, Republic ofBahrain, Kingdom ofBangladesh, People’s Republic …

State seeks federal waiver to cut drug costs Read More »

Cigna's PBM Express scripts latest to put Abbvie's cheaper Humira biosimilars on preferred drug list

Cigna’s PBM Express scripts latest to put Abbvie’s cheaper Humira biosimilars on preferred drug list

Leave a Comment / Health care / By

Cigna’s pharmacy benefits manager, Express Scripts, will offer “multiple” biosimilar versions of Abbvie … [+] the expensive rheumatoid arthritis drug Humira in the “same position as the brand” on PBMs as a formulary in 2023. AbbVie’s signature drug, Humira, is shown in this illustration Friday, July 18, 2014, in Houston. (AP Photo/David J. Phillip) Copyright …

Cigna’s PBM Express scripts latest to put Abbvie’s cheaper Humira biosimilars on preferred drug list Read More »

Here's When Drug Prices Will Start Falling for Medicare Beneficiaries - Louisiana Illuminator

Here’s When Drug Prices Will Start Falling for Medicare Beneficiaries – Louisiana Illuminator

Leave a Comment / Health care / By

Starting next month, a $35 cap on insulin prices will go into effect for millions of Medicare beneficiaries. The price cut is one of the first of several policy moves Americans will see in the months and years to come under the Cut Inflation Act signed into law in August. The bill also requires drug …

Here’s When Drug Prices Will Start Falling for Medicare Beneficiaries – Louisiana Illuminator Read More »

1950s-themed senior centers are providing comfort for people with Alzheimer

Experimental Alzheimer’s drug may slow disease progression, but there are risks: experts

Leave a Comment / Health / By

The experimental drug lecanemab showed a 27% slowing of the progression of cognitive decline in patients with early-stage Alzheimer’s disease, according to a study published this week in the New England Journal of Medicine. “These results show that lecanemab shows promise for people with early-stage Alzheimer’s disease, with a significant slowing of decline and a …

Experimental Alzheimer’s drug may slow disease progression, but there are risks: experts Read More »

mlive’s Logo

Drug study to examine Alzheimer’s disease prevention, research Michigan participants

Leave a Comment / Health / By

An as yet unapproved drug shows promise for reducing cognitive decline in patients with Alzheimer’s disease. Whether it might work to prevent disease progression is the question in a new clinical trial of lecanemab, a monoclonal antibody developed by Japanese pharmaceutical company Eisai and Biogen of Massachusetts. Michigan’s only site, at the University of Michigan …

Drug study to examine Alzheimer’s disease prevention, research Michigan participants Read More »

The Swedish scientist behind the Alzheimer's drug has big ambitions

The Swedish scientist behind the Alzheimer’s drug has big ambitions

Leave a Comment / Health / By

As Japanese drugmaker Eisai this week presented data confirming it had developed the first drug to slow cognitive decline in Alzheimer’s patients, audiences at a conference in San Francisco erupted in applause. Among those present was Lars Lannfelt, a little-known Swedish scientist who invented the breakthrough drug, known as lecanemab, and will make a fortune …

The Swedish scientist behind the Alzheimer’s drug has big ambitions Read More »

Neuroscience News logo for mobile.

New drug, promising breakthrough for incurable neurodegenerative myelin diseases – Neuroscience News

Leave a Comment / Health / By

Summary: Riluzole, an FDA-approved drug to treat ALS, may, in part, correct the molecular cause of some leukodystrophies. Source: Montreal university There is new hope for the future treatment of certain leukodystrophies, neurodegenerative diseases in young children that progressively affect their quality of life, often leading to death before adulthood. The development stems from the …

New drug, promising breakthrough for incurable neurodegenerative myelin diseases – Neuroscience News Read More »